These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25237)

  • 1. [Comparative studies on the protective effect of etilefrin and dihydroergotamine in circulatory instability after blood donation].
    Müller V; Heiss F; Singh M
    Fortschr Med; 1978 May; 96(17):935-8. PubMed ID: 25237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormalities of hypotonic orthostatic regulation: cardiovascular effects of dihydroergotamine, etilefrine and their combination (author's transl)].
    Gemeinhardt S; Schardt F; Polzien P
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1095-9. PubMed ID: 6114845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
    Polzien P; Bracharz H
    Med Klin; 1980 Dec; 75(25):878-82. PubMed ID: 6110162
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypotensive circulatory dysregulation with a combination of dihydroergotamine and etilefrine (author's transl)].
    Bracharz H; Polzien P
    MMW Munch Med Wochenschr; 1981 Jan; 123(5):177-80. PubMed ID: 6110188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic aspects of orthostatic dysfunction].
    Rieckert H
    Med Klin Prax; 1982 Feb; 77(5):48-52. PubMed ID: 6123069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
    Schardt F
    Med Welt; 1981 Feb; 32(6):194-8. PubMed ID: 6110159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the effects of etilefrin and dihydroergotamine in management of the orthostatic syndrome].
    ZFA (Stuttgart); 1979 Mar; 55(8):545-8. PubMed ID: 34284
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the effectiveness of Thomasin (etilefrin) in hypotensive and/or orthostatic circulatory disorders in comparison with pholedrine and placebo (double-blind study)].
    Gruber G
    Z Arztl Fortbild (Jena); 1982 Feb; 76(4):149-53. PubMed ID: 6125062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled comparison of dihydroergotamine and etilofrin in orthostatic syndrome].
    Garbe WE; Clasen J
    Med Welt; 1978 Jun; 29(22):939-42. PubMed ID: 26009
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of etilefrine and dihydroergotamine on sympathetic nervous system activity when standing up (author's transl)].
    Kaden F; Mäurer W; Schömig A; Spohr U
    Dtsch Med Wochenschr; 1978 Sep; 103(39):1513-7. PubMed ID: 28936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Orthostatic hypotension in the aged subject].
    de Brito Paiva E; Constantinescu M; Treuer E
    Rev Med Suisse Romande; 1983 Jan; 103(1):43-9. PubMed ID: 6133336
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the action of antihypotensive agents in sympathicotonic orthostatic hypotension in geriartric patients: comparison between placebo and etilefrin (author's transl)].
    Birke ER
    Med Klin; 1977 Oct; 72(41):1696-702. PubMed ID: 21345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies of the efficacy of amezinium and etilefrin in aged patients with hypotonic blood circulation regulatory disorders].
    Jansen W
    Med Welt; 1982 Oct; 32(40):1491-6. PubMed ID: 6125868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dihydergot plus - 12-hour action in orthostatic disturbance and hypotension].
    Schardt F; Mishra BR
    Ther Ggw; 1982 Jan; 121(1):26-36. PubMed ID: 6121387
    [No Abstract]   [Full Text] [Related]  

  • 15. [The hypertensive effect of adyston and etilefrin. Comparative animal experimental studies].
    Statkov PR
    Fortschr Med; 1978 May; 96(19):1046-8. PubMed ID: 25832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dihydroergot plus in the long-term therapy of orthostatic hypotonic dysregulation in older patients].
    Muth HH; Jansen W
    Fortschr Med; 1980 Oct; 98(40):1571-4. PubMed ID: 6109687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamics of etilfrine pivilate in the orthostatic syndrome].
    Hengstmann JH; Brecht T; Ewers W
    Arzneimittelforschung; 1986 May; 36(5):874-7. PubMed ID: 2873822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double blind study of migraine therapy with etilefrine pivalate].
    Cruz A; Bühling M; Seibel K
    Arzneimittelforschung; 1985; 35(7):1086-9. PubMed ID: 2864937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results with the antihypotensive agent Thomasin (etilefrin) under ambulatory conditions (a double-blind study)].
    Bismarck M; Rust G
    Z Arztl Fortbild (Jena); 1982 Feb; 76(4):153-6. PubMed ID: 6125063
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.
    Thulesius O; Berlin E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):465-7. PubMed ID: 2877953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.